BRAVE: Building Resilience and Values Through E-health

Stanford University (Other)
Overall Status
Recruiting ID

Study Details

Study Description

Brief Summary

The purpose of this study is to determine the feasibility and acceptability of tracking survivors' and their caregivers, stressors, affect, and symptoms using an electronic diary method, in the time period surrounding their routine check- up with their oncologist.

Condition or Disease Intervention/Treatment Phase
  • Other: Online survey questionnaire

Study Design

Study Type:
Anticipated Enrollment :
62 participants
Intervention Model:
Single Group Assignment
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
BRAVE: Building Resilience and Values Through E-health
Actual Study Start Date :
Mar 1, 2021
Anticipated Primary Completion Date :
Mar 1, 2023
Anticipated Study Completion Date :
Mar 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Other: Daily Diary Method Cohort

Participants will be asked to complete a self-report questionnaire that has been validated to assess daily affect. There are 5 items assessing positive affect (joyful, cheerful, happy, lively, proud) and 5 items assessing negative affect (miserable, mad, afraid, scared sad). The respondent is asked to rate these 10 different feelings on a 5-point Likert scale from 1, "not much or not at all" to 5, "a lot."

Other: Online survey questionnaire
Participants will complete a brief online survey every morning and evening within 1 hour of waking and 1 hour of going to sleep. The surveys will be a combination of measures used to assess affect, stress, and symptoms

Outcome Measures

Primary Outcome Measures

  1. Online survey questionnaire [21 days]

    participants will complete a brief online survey every morning and evening within 1 hour of waking and 1 hour of going to sleep

Eligibility Criteria


Ages Eligible for Study:
11 Years to 25 Years
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Inclusion Criteria:
  1. 11-25 years old

  2. previously received a pediatric cancer diagnosis and treatment for such

  3. completed cancer treatment <5 years ago, in remission

  4. Own a smart phone or tablet

  5. are English proficient

Exclusion Criteria:
  • no cognitive, motor, or sensory deficits that could preclude completion of study measures.

Contacts and Locations


Site City State Country Postal Code
1 Stanford University San Francisco California United States 94305

Sponsors and Collaborators

  • Stanford University


  • Principal Investigator: Claudia Mueller, MD, PhD, Stanford University

Study Documents (Full-Text)

None provided.

More Information


None provided.
Responsible Party:
Stanford University Identifier:
Other Study ID Numbers:
  • IRB-55183
First Posted:
Feb 7, 2022
Last Update Posted:
Feb 7, 2022
Last Verified:
Jan 1, 2022
Studies a U.S. FDA-regulated Drug Product:
Studies a U.S. FDA-regulated Device Product:

Study Results

No Results Posted as of Feb 7, 2022